{"id":1871,"date":"2023-05-29T14:08:53","date_gmt":"2023-05-29T12:08:53","guid":{"rendered":"https:\/\/solmed-clinic.com\/?post_type=ispitivanja&#038;p=1871"},"modified":"2024-07-01T20:29:24","modified_gmt":"2024-07-01T18:29:24","slug":"hidradenitis-suppurativa-acne-inversa","status":"publish","type":"ispitivanja","link":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/","title":{"rendered":"Hidradenitis Suppurativa (JAK-1 Study)"},"content":{"rendered":"<h3>Location: Solmed Polyclinic (Zagreb), SB Medico (Rijeka)<\/h3>\n<p><strong>Study Drug:<\/strong> Biological therapy, selective JAK-1 inhibitor, already registered for other diseases.<\/p>\n<p><strong>Main Inclusion Criteria:<\/strong> Patients older than 18 years who, with or after adalimumab therapy (biological therapy), have symptoms consistent with moderate to severe hidradenitis suppurativa.<\/p>\n<h3>Status: <span style=\"color: #339966;\">Enrolling new patients<\/span><\/h3>\n<p>Start of Patient Enrollment: November 2023<\/p>\n<p>Planned Completion of New Patient Enrollment: July 2025<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Location: Solmed Polyclinic (Zagreb), SB Medico (Rijeka) Study Drug: Biological therapy, selective JAK-1 inhibitor, already registered for other diseases. Main Inclusion Criteria: Patients older than 18 years who, with or &#8230;<\/p>\n","protected":false},"featured_media":1867,"template":"","status_ispitivanja":[81],"podrucja":[112,113],"class_list":["post-1871","ispitivanja","type-ispitivanja","status-publish","has-post-thumbnail","hentry","status_ispitivanja-includes-patients","podrucja-allergology-and-immunology","podrucja-dermatology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hidradenitis Suppurativa (JAK-1 Study) - Solmed Clinic<\/title>\n<meta name=\"description\" content=\"Hidradenitis Suppurativa (Acne Inversa), anti-IL-1\u03b1 and IL-1\u03b2 dual monoclonal antibody, Lutikizumab\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hidradenitis Suppurativa (JAK-1 Study) - Solmed Clinic\" \/>\n<meta property=\"og:description\" content=\"Hidradenitis Suppurativa (Acne Inversa), anti-IL-1\u03b1 and IL-1\u03b2 dual monoclonal antibody, Lutikizumab\" \/>\n<meta property=\"og:url\" content=\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/\" \/>\n<meta property=\"og:site_name\" content=\"Solmed Clinic\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/solmedgrupa\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-01T18:29:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2023\/05\/HS-slika.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"713\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/\",\"url\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/\",\"name\":\"Hidradenitis Suppurativa (JAK-1 Study) - Solmed Clinic\",\"isPartOf\":{\"@id\":\"https:\/\/solmed-clinic.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2023\/05\/HS-slika.jpg\",\"datePublished\":\"2023-05-29T12:08:53+00:00\",\"dateModified\":\"2024-07-01T18:29:24+00:00\",\"description\":\"Hidradenitis Suppurativa (Acne Inversa), anti-IL-1\u03b1 and IL-1\u03b2 dual monoclonal antibody, Lutikizumab\",\"breadcrumb\":{\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/#primaryimage\",\"url\":\"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2023\/05\/HS-slika.jpg\",\"contentUrl\":\"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2023\/05\/HS-slika.jpg\",\"width\":1024,\"height\":713},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Po\u010detna stranica\",\"item\":\"https:\/\/solmed-clinic.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hidradenitis Suppurativa (JAK-1 Study)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/solmed-clinic.com\/#website\",\"url\":\"https:\/\/solmed-clinic.com\/\",\"name\":\"Solmed Clinic\",\"description\":\"Solutions in medicine\",\"publisher\":{\"@id\":\"https:\/\/solmed-clinic.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/solmed-clinic.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/solmed-clinic.com\/#organization\",\"name\":\"Solmed Clinic\",\"url\":\"https:\/\/solmed-clinic.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg\",\"contentUrl\":\"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg\",\"width\":482,\"height\":77,\"caption\":\"Solmed Clinic\"},\"image\":{\"@id\":\"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/solmedgrupa\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hidradenitis Suppurativa (JAK-1 Study) - Solmed Clinic","description":"Hidradenitis Suppurativa (Acne Inversa), anti-IL-1\u03b1 and IL-1\u03b2 dual monoclonal antibody, Lutikizumab","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/","og_locale":"en_US","og_type":"article","og_title":"Hidradenitis Suppurativa (JAK-1 Study) - Solmed Clinic","og_description":"Hidradenitis Suppurativa (Acne Inversa), anti-IL-1\u03b1 and IL-1\u03b2 dual monoclonal antibody, Lutikizumab","og_url":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/","og_site_name":"Solmed Clinic","article_publisher":"https:\/\/www.facebook.com\/solmedgrupa","article_modified_time":"2024-07-01T18:29:24+00:00","og_image":[{"width":1024,"height":713,"url":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2023\/05\/HS-slika.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/","url":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/","name":"Hidradenitis Suppurativa (JAK-1 Study) - Solmed Clinic","isPartOf":{"@id":"https:\/\/solmed-clinic.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/#primaryimage"},"image":{"@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/#primaryimage"},"thumbnailUrl":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2023\/05\/HS-slika.jpg","datePublished":"2023-05-29T12:08:53+00:00","dateModified":"2024-07-01T18:29:24+00:00","description":"Hidradenitis Suppurativa (Acne Inversa), anti-IL-1\u03b1 and IL-1\u03b2 dual monoclonal antibody, Lutikizumab","breadcrumb":{"@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/#primaryimage","url":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2023\/05\/HS-slika.jpg","contentUrl":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2023\/05\/HS-slika.jpg","width":1024,"height":713},{"@type":"BreadcrumbList","@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/hidradenitis-suppurativa-acne-inversa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Po\u010detna stranica","item":"https:\/\/solmed-clinic.com\/en\/"},{"@type":"ListItem","position":2,"name":"Hidradenitis Suppurativa (JAK-1 Study)"}]},{"@type":"WebSite","@id":"https:\/\/solmed-clinic.com\/#website","url":"https:\/\/solmed-clinic.com\/","name":"Solmed Clinic","description":"Solutions in medicine","publisher":{"@id":"https:\/\/solmed-clinic.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/solmed-clinic.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/solmed-clinic.com\/#organization","name":"Solmed Clinic","url":"https:\/\/solmed-clinic.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/","url":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg","contentUrl":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg","width":482,"height":77,"caption":"Solmed Clinic"},"image":{"@id":"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/solmedgrupa"]}]}},"_links":{"self":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja\/1871","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja"}],"about":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/types\/ispitivanja"}],"version-history":[{"count":8,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja\/1871\/revisions"}],"predecessor-version":[{"id":3860,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja\/1871\/revisions\/3860"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/media\/1867"}],"wp:attachment":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/media?parent=1871"}],"wp:term":[{"taxonomy":"status_ispitivanja","embeddable":true,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/status_ispitivanja?post=1871"},{"taxonomy":"podrucja","embeddable":true,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/podrucja?post=1871"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}